Literature DB >> 12433654

Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide.

Norbert Weissmann1, Matthias Nollen, Boris Gerigk, Hossein Ardeschir Ghofrani, Ralph Theo Schermuly, Andreas Gunther, Karin Quanz, Ludger Fink, Jörg Hänze, Frank Rose, Werner Seeger, Friedrich Grimminger.   

Abstract

Hypoxic pulmonary vasoconstriction (HPV) matches lung perfusion to ventilation for optimizing pulmonary gas exchange. Chronic alveolar hypoxia results in vascular remodeling and pulmonary hypertension. Previous studies have reported conflicting results of the effect of chronic alveolar hypoxia on pulmonary vasoreactivity and the contribution of nitric oxide (NO), which may be related to species and strain differences as well as to the duration of chronic hypoxia. Therefore, we investigated the impact of chronic hypoxia on HPV in rabbits, with a focus on lung NO synthesis. After exposure of the animals to normobaric hypoxia (10% O(2)) for 1 day to 10 wk, vascular reactivity was investigated in ex vivo perfused normoxic ventilated lungs. Chronic hypoxia induced right heart hypertrophy and increased normoxic vascular tone within weeks. The vasoconstrictor response to an acute hypoxic challenge was strongly downregulated within 5 days, whereas the vasoconstrictor response to the thromboxane mimetic U-46619 was maintained. The rapid downregulation of HPV was apparently not linked to changes in the lung vascular NO system, detectable in the exhaled gas and by pharmacological blockage of NO synthesis. Treatment of the animals with long-term inhaled NO reduced right heart hypertrophy and partially maintained the reactivity to acute hypoxia, without any impact on the endogenous NO system being noted. We conclude that chronic hypoxia causes rapid downregulation of acute HPV as a specific event, preceding the development of major pulmonary hypertension and being independent of the lung vascular NO system. Long-term NO inhalation partially maintains the strength of the hypoxic vasoconstrictor response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12433654     DOI: 10.1152/ajpheart.00376.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  10 in total

1.  Nestin-expressing vascular wall cells drive development of pulmonary hypertension.

Authors:  Farhan Saboor; Ansgar N Reckmann; Claudia U M Tomczyk; Dorothea M Peters; Norbert Weissmann; Andre Kaschtanow; Ralph T Schermuly; Tatyana V Michurina; Grigori Enikolopov; Dieter Müller; Andrea Mietens; Ralf Middendorff
Journal:  Eur Respir J       Date:  2015-12-23       Impact factor: 16.671

2.  Reversal of experimental pulmonary hypertension by PDGF inhibition.

Authors:  Ralph Theo Schermuly; Eva Dony; Hossein Ardeschir Ghofrani; Soni Pullamsetti; Rajkumar Savai; Markus Roth; Akylbek Sydykov; Ying Ju Lai; Norbert Weissmann; Werner Seeger; Friedrich Grimminger
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 3.  Relationships between vascular oxygen sensing mechanisms and hypertensive disease processes.

Authors:  Sachin A Gupte; Michael S Wolin
Journal:  Hypertension       Date:  2012-06-18       Impact factor: 10.190

Review 4.  Antenatal hypoxia and pulmonary vascular function and remodeling.

Authors:  Demosthenes G Papamatheakis; Arlin B Blood; Joon H Kim; Sean M Wilson
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

5.  Classical transient receptor potential 1 and 6 contribute to hypoxic pulmonary hypertension through differential regulation of pulmonary vascular functions.

Authors:  Yang Xia; Xiao-Ru Yang; Zhenzhen Fu; Omkar Paudel; Joel Abramowitz; Lutz Birnbaumer; James S K Sham
Journal:  Hypertension       Date:  2013-10-21       Impact factor: 10.190

6.  Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice.

Authors:  Renate Paddenberg; Philipp Stieger; Anna-Laura von Lilien; Petra Faulhammer; Anna Goldenberg; Harald H Tillmanns; Wolfgang Kummer; Ruediger C Braun-Dullaeus
Journal:  Respir Res       Date:  2007-02-24

7.  Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats.

Authors:  Hae Jin Kim; Hae Young Yoo
Journal:  Korean J Physiol Pharmacol       Date:  2016-10-28       Impact factor: 2.016

Review 8.  Gestational Hypoxia and Programing of Lung Metabolism.

Authors:  Kristiana Rood; Vanessa Lopez; Michael R La Frano; Oliver Fiehn; Lubo Zhang; Arlin B Blood; Sean M Wilson
Journal:  Front Physiol       Date:  2019-11-29       Impact factor: 4.566

9.  AMPK deficiency in smooth muscles causes persistent pulmonary hypertension of the new-born and premature death.

Authors:  Javier Moral-Sanz; Sophronia A Lewis; Sandy MacMillan; Marco Meloni; Heather McClafferty; Benoit Viollet; Marc Foretz; Jorge Del-Pozo; A Mark Evans
Journal:  Nat Commun       Date:  2022-08-26       Impact factor: 17.694

10.  Disappearance of hypoxic pulmonary vasoconstriction and o2-sensitive nonselective cationic current in arterial myocytes of rats under ambient hypoxia.

Authors:  Hae Young Yoo; Sung Joon Kim
Journal:  Korean J Physiol Pharmacol       Date:  2013-10-17       Impact factor: 2.016

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.